Ckd Bio (063160) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.006x

Based on the latest financial reports, Ckd Bio (063160) has a cash flow conversion efficiency ratio of 0.006x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩771.88 Million ≈ $523.10K USD) by net assets (₩125.00 Billion ≈ $84.71 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 063160 equity to assets ratio to measure how much of total assets are equity-financed.

Ckd Bio - Cash Flow Conversion Efficiency Trend (2008–2025)

This chart illustrates how Ckd Bio's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Ckd Bio earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.

Ckd Bio Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Ckd Bio ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Taiwan Alpha Electronic Co Ltd TWO:6204	0.009x
CTI Traffic Industries Co Ltd TWO:2230	-0.134x
SIL Investments Limited NSE:SILINV	0.027x
Immutep Ltd AU:IMM	-0.233x
Facephi Biometria SA MC:FACE	0.310x
Korea Parts & Fasteners Co.Ltd KQ:024880	0.085x
SKB Shutters Corporation Bhd KLSE:7115	-0.003x
Mondi PLC LSE:MNDI	0.119x

Annual Cash Flow Conversion Efficiency for Ckd Bio (2008–2025)

The table below shows the annual cash flow conversion efficiency of Ckd Bio from 2008 to 2025. For the full company profile with market capitalisation and key ratios, see 063160 company net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩127.04 Billion ≈ $86.09 Million	₩-4.14 Billion ≈ $-2.81 Million	-0.033x	-130.45%
2024-12-31	₩131.01 Billion ≈ $88.78 Million	₩14.03 Billion ≈ $9.51 Million	0.107x	+282.39%
2023-12-31	₩123.02 Billion ≈ $83.37 Million	₩-7.22 Billion ≈ $-4.90 Million	-0.059x	-170.82%
2022-12-31	₩147.80 Billion ≈ $100.16 Million	₩-3.20 Billion ≈ $-2.17 Million	-0.022x	+40.47%
2021-12-31	₩161.49 Billion ≈ $109.44 Million	₩-5.88 Billion ≈ $-3.99 Million	-0.036x	-227.41%
2020-12-31	₩168.75 Billion ≈ $114.36 Million	₩4.82 Billion ≈ $3.27 Million	0.029x	-73.34%
2019-12-31	₩158.46 Billion ≈ $107.39 Million	₩16.99 Billion ≈ $11.51 Million	0.107x	+1.91%
2018-12-31	₩147.66 Billion ≈ $100.07 Million	₩15.54 Billion ≈ $10.53 Million	0.105x	-26.90%
2017-12-31	₩142.05 Billion ≈ $96.26 Million	₩20.45 Billion ≈ $13.86 Million	0.144x	+25.52%
2016-12-31	₩135.16 Billion ≈ $91.60 Million	₩15.50 Billion ≈ $10.50 Million	0.115x	+1.87%
2015-12-31	₩127.38 Billion ≈ $86.32 Million	₩14.34 Billion ≈ $9.72 Million	0.113x	+22.22%
2014-12-31	₩121.85 Billion ≈ $82.57 Million	₩11.22 Billion ≈ $7.61 Million	0.092x	+4.45%
2013-12-31	₩123.87 Billion ≈ $83.95 Million	₩10.92 Billion ≈ $7.40 Million	0.088x	-52.19%
2012-12-31	₩124.15 Billion ≈ $84.13 Million	₩22.90 Billion ≈ $15.52 Million	0.184x	+69.33%
2011-12-31	₩119.00 Billion ≈ $80.65 Million	₩12.96 Billion ≈ $8.79 Million	0.109x	-65.28%
2010-12-31	₩76.14 Billion ≈ $51.60 Million	₩23.89 Billion ≈ $16.19 Million	0.314x	-24.35%
2009-12-31	₩64.08 Billion ≈ $43.42 Million	₩26.57 Billion ≈ $18.01 Million	0.415x	+90.70%
2008-12-31	₩49.15 Billion ≈ $33.31 Million	₩10.69 Billion ≈ $7.24 Million	0.217x	--

About Ckd Bio

KO:063160 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$47.88 Million

₩70.66 Billion KRW

Market Cap Rank

#21989 Global

#1315 in Korea

Share Price

₩12880.00

Change (1 day)

+1.66%

52-Week Range

₩12200.00 - ₩24500.00

All Time High

₩101057.67